當前位置：首頁 JCRQ1 期刊介紹(非官網(wǎng))

Drug Delivery And Translational ResearchSCIE

國際簡稱：DRUG DELIV TRANSL RE 參考譯名：藥物輸送和轉化研究

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q1

基本信息：: ISSN：2190-393X; E-ISSN：2190-3948; 是否OA：未開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區(qū)：GERMANY; 出版商：Springer US; 出版語言：English; 出版周期：12 issues per year; 出版年份：2011; 研究方向：MEDICINE, RESEARCH & EXPERIMENTALPHARMACOL-PHARMACOLOGY & PHARMACY

評價信息：: 影響因子：5.7; H-index：27; CiteScore指數(shù)：11.7; SJR指數(shù)：0.994; SNIP指數(shù)：1.147

發(fā)文數(shù)據(jù)：: Gold OA文章占比：27.38%; 研究類文章占比：86.70%; 年發(fā)文量：203; 自引率：0.0185...; 開源占比：0.2037; 出版撤稿占比：0; 出版國人文章占比：0.12; OA被引用占比：0.1919...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Drug Delivery And Translational Research期刊介紹

The journal provides a unique forum for scientific publication of high-quality research that is exclusively focused on translational aspects of drug delivery. Rationally developed, effective delivery systems can potentially affect clinical outcome in different disease conditions.

Research focused on the following areas of translational drug delivery research will be considered for publication in the journal.

Designing and developing novel drug delivery systems, with a focus on their application to disease conditions;

Preclinical and clinical data related to drug delivery systems;

Drug distribution, pharmacokinetics, clearance, with drug delivery systems as compared to traditional dosing to demonstrate beneficial outcomes

Short-term and long-term biocompatibility of drug delivery systems, host response;

Biomaterials with growth factors for stem-cell differentiation in regenerative medicine and tissue engineering;

Image-guided drug therapy,

Nanomedicine;

Devices for drug delivery and drug/device combination products.

In addition to original full-length papers, communications, and reviews, the journal includes editorials, reports of future meetings, research highlights, and announcements pertaining to the activities of the Controlled Release Society.

期刊簡介Drug Delivery And Translational Research期刊介紹

《Drug Delivery And Translational Research》自2011出版以來，是一本醫(yī)學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結果，并為醫(yī)學各個領域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學領域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

預計審稿時間：
醫(yī)學
PHARMACOLOGY & PHARMACY
SCIE
中科院3區(qū)
非預警

Cite Score數(shù)據(jù)（2024年最新版）Drug Delivery And Translational Research Cite Score數(shù)據(jù)

CiteScore：11.7
SJR：0.994
SNIP：1.147

學科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmaceutical Science	Q1	11 / 183	94%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Drug Delivery And Translational Research 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
醫(yī)學	3區(qū)	PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗	2區(qū) 3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎，運用科學計量學方法對國際、國內學術期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構的管理人員、科研工作者提供了一份評價國際學術期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術期刊質量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Drug Delivery And Translational Research JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	32 / 189	83.3%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	30 / 354	91.7%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	30 / 189	84.39%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q1	38 / 354	89.41%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術文獻質量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
India103
USA88
CHINA MAINLAND76
Egypt35
England30
Brazil27
Malaysia23
Iran22
Italy22
Australia18

本刊中國學者近年發(fā)表論文

1、Development and characterization of gastro-floating sustained-release capsule with improved bioavailability of levodopa
Author: Yuan, Hao; Zhang, Zhengyu; Hu, Liandong

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 1, pp. 9-17. DOI: 10.1007/s13346-022-01188-5
2、Development, characterisation, and in vitro anti-tumor effect of self-microemulsifying drug delivery system containing polyphyllin I
Author: Wang, Xin; Zhang, Rui; Wang, Shu; Gu, Minju; Li, Yuan; Zhuang, Xiuping; Chen, Chao; Yang, Peimin; Guo, Gongling; Sun, Ping

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 1, pp. 356-370. DOI: 10.1007/s13346-022-01212-8
3、Light-related activities of metal-based nanoparticles and their implications on dermatological treatment
Author: Wang, Qiuyue; Chen, Naiying; Li, Mingming; Yao, Sicheng; Sun, Xinxing; Feng, Xun; Chen, Yang

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 2, pp. 386-399. DOI: 10.1007/s13346-022-01216-4
4、A topical thermosensitive hydrogel system with cyclosporine A PEG-PCL micelles alleviates ulcerative colitis induced by TNBS in mice
Author: Xiao, Chuyao; Li, Genyun; Li, Xiaoyue; Wang, Dan; Wu, Ya; Sun, Minghui; Huang, Jiangeng; Si, Luqin

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s13346-023-01317-8
5、Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression
Author: You, Song; Luo, Zijin; Cheng, Niangmei; Wu, Ming; Lai, Yongping; Wang, Fei; Zheng, Xiaoyuan; Wang, Yingchao; Liu, Xiaolong; Liu, Jingfeng; Zhao, Bixing

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 3, pp. 782-794. DOI: 10.1007/s13346-022-01237-z
6、Ocular barriers as a double-edged sword: preventing and facilitating drug delivery to the retina
Author: Wang, Lixiang; Zhang, Hui

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 2, pp. 547-567. DOI: 10.1007/s13346-022-01231-5
7、Pirfenidone-loaded hyaluronic acid methacryloyl hydrogel for preventing epidural adhesions after laminectomy
Author: Ji, Jiawei; Cheng, Jiaqi; Chen, Cheng; Lu, Yang; Chen, Xiaoqing; Zhang, Feng

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 3, pp. 770-781. DOI: 10.1007/s13346-022-01236-0
8、Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system
Author: Liu, Hui; Su, Yu-Yan; Jiang, Xin-Chi; Gao, Jian-Qing

Journal: DRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2023; Vol. 13, Issue 3, pp. 716-737. DOI: 10.1007/s13346-022-01252-0